期刊文献+

肿瘤细胞免疫原性死亡中特征性表达抗原在抗瘤免疫应答中的作用 被引量:5

The role of characteristic antigens expression in the immunogenic tumor cell death
在线阅读 下载PDF
导出
摘要 最新研究显示凋亡并非是一种均一的细胞死亡方式,研究发现:通过高温、射线、化疗药物等一些手段处理肿瘤细胞并引起其凋亡的同时细胞表面表达引起机体免疫攻击的蛋白分子,从而引起抗肿瘤免疫反应,被称为肿瘤的免疫原性死亡。免疫原性死亡的肿瘤细胞表面高表达钙网蛋白、热休克蛋白、高迁移率族蛋白B1等引起机体免疫反应的抗原分子能够提高树突状细胞识别肿瘤细胞的能力,激活肿瘤特异性的细胞毒性T淋巴细胞对肿瘤的攻击。肿瘤细胞免疫原性死亡及其特征性表达抗原为肿瘤生物治疗提供了新的治疗依据和手段。 The latest research shows that apoptosis is not a uniform way of cell death,and the study found that the dying tumor cells express characteristic antigens which could cause anti-tumor immune response when the apoptosis of tumor cells caused by high temperature,radiation,some kinds of chemotherapy drugs and many other means.This kind of tumor cell death is called immunogenic cell death.The high expression of the characteristic antigens on the dying tumor cells is a notable feature of immunogenic cell death which could improve the capability of dendritic cells (DC) to identify tumor cells and activate tumor-specific cytotoxic T lymphocytes (CTL) against tumors.The characteristic antigens include calreticulin (CRT),heat shock proteins (HSPs),high mobility group protein B1 (HMGB-1) and so on.Immunogenic tumor cell death provides a new mechanism to explain how anti-tumor chemotherapy drugs kill tumor cells,and also provides a new theory to the cancer biotherapy.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第8期730-734,共5页 Immunological Journal
基金 河北省科学技术研究与发展计划资助项目(09276418D-26) 河北省医学实用技术跟踪项目(GL200928)
关键词 肿瘤 免疫原性死亡 树突状细胞 钙网蛋白 热休克蛋白 高迁移率族蛋白B1 Tumor Immunogenic cell death Dendritic cell CRT HSPs HMGB-1
  • 相关文献

参考文献30

  • 1Amaravadi RK, Thompson CB. The roles of therapy-induced autophagy and necrosis in cancer treatment [J]. Clin Cancer Res, 2007, 13(24): 7271-7279.
  • 2Blankenberg FG. In vivo imaging of apoptosis[J]. Cancer Biol Ther, 2008, 7(10): 1525-1532.
  • 3Green DR, Ferguson T, Zitvogel L, et al. Immunogenic and tolerogenic cell death [J]. Nat Rev Immunol, 2009, 9 (5): 353-363.
  • 4Kepp O, Tesniere A, Zitvogel L, et al.The immunogenicity of tumor cell death[J]. Curr Opin Oncol, 2009, 21(1): 71-76.
  • 5Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death [J]. Nat Med, 2007, 13(1): 54-61.
  • 6Panaretakis T, Kepp O, Brockmeier U, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death[J]. Embo J, 2009, 28(5): 578-590.
  • 7Panaretakis T, Joza N, Modjtahedi N, et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death [J]. Cell Death Differ, 2008, 15 (9): 1499-1509.
  • 8Obeid M, Panaretakis T, Joza N, et al. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis[J]. Cell Death Differ, 2007, 14: 1848-1850.
  • 9Williams DB. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum[J]. J Cell Sci, 2006, 119(4): 615-623.
  • 10Kim SG, Park MY, Kim CH, et al. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination[J]. Vaccine, 2008, 26(50): 6433- 6440.

同被引文献61

  • 1刘莉,丁乾,姚军霞,宋颖秋,曹如波,黄士昂.放射损伤对鼻咽癌外周血CD4^+CD25^(high)调节性T细胞的影响[J].中华放射医学与防护杂志,2006,26(1):31-34. 被引量:12
  • 2曾蓉,陈燕.急性红白血病的生物学特征与临床疗效研究[J].中国实验血液学杂志,2007,15(3):466-469. 被引量:11
  • 3Zitvogel L,Apetoh L,Ghiringhelli F,et al.The anticancer immune response:indispensable for therapeutic success?[J].J Clin Invest,2008,118(6):1991-2001.
  • 4Neninger E,Verdecia BG,Crombet T,et al.Combining an EGF-based cancer vaccine with chemotherapy in advanced nonsmall cell lung cancer[J].J Immunother,2009,32(1):92-99.
  • 5Kepp O,Tesniere A,Schlemmer F,et al.Immunogenic cell death modalities and their impact on cancer treatment[J].Apoptosis,2009,14(4):364-375.
  • 6Calderwood SK,Mambula SS,Gray PJ Jr,et al.Extracellular heat shock proteins in cell signaling[J].FEBS Lett,2007,581(19):3689-3694.
  • 7Dumitriu IE,Bianchi ME,Bacci M,et al.The secretion of HMGB1 is required for the migration of maturing dendritic cells[J].J Leukoc Biol,2007,81(1):84-91.
  • 8Obeid M,Panaretakis T,Joza N,et al.Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis[J].Cell Death Differ,2007,14(10):1848-1850.
  • 9Kepp O,Tesniere A,Zitvogel L,et al.The immunogenicity of tumor cell death[J].Curr Opin Oncol,2009,21(1):71-76.
  • 10Brusa D,Garetto S,Chiorino G,et al.Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity[J].Vaccine,2008,26(50):6422-6432.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部